ArticleCancer medicine2024

Hepatic arterial infusion chemotherapy, lenvatinib plus programmed cell death protein-1 inhibitors: A promising treatment approach for high-burden hepatocellular carcinoma.

Shumin Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.